Stocks · Korea
293480
KOSPI
Hana Pharm
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER16.73x
PBR0.48x
EPS507 KRW
BPS17,808 KRW
ROE4.55%
Dividend yield3.07%
DPS260 KRW
Payout ratio51.28%
Returns and 52-week range
1W+2.79%
1M+0.71%
3M-2.19%
6M-9.01%
1Y-30.55%
YTD-23.05%
52W high12,300원
52W low8,100원
From 52W high-31.06%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 2,108억 | 312억 | 243억 | 14.8% |
| 2023 | 2,245억 | 270억 | 223억 | 12.0% |
| 2024 | 2,253억 | 252억 | 213억 | 11.2% |
| 2025 | 2,395억 | 258억 | 88억 | 10.8% |
| Quarterly | ||||
| 2024 4Q | 575억 | 89억 | 72억 | 15.6% |
| 2025 1Q | 575억 | 56억 | 42억 | 9.8% |
| 2025 2Q | 579억 | 60억 | 55억 | 10.4% |
| 2025 3Q | 638억 | 83억 | -43억 | 13.1% |
| 2025 4Q | 604억 | 58억 | 33억 | 9.7% |
| 2026 1Q | 623억 | 71억 | 100억 | 11.4% |
Company
Address: 경기도 화성시 향남읍 제약단지로 13-39
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
- 2026-03-20사업보고서 (2025.12)
- 2026-01-23주요사항보고서(자기주식처분결정) Major
- 2025-12-24[기재정정]주요사항보고서(자기주식처분결정) Major
- 2025-12-24주요사항보고서(자기주식처분결정) Major
- 2025-11-14분기보고서 (2025.09)
- 2025-08-14반기보고서 (2025.06)
- 2025-05-15분기보고서 (2025.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.